Azad David 4
4 · ACURA PHARMACEUTICALS, INC · Filed Jan 3, 2012
Insider Transaction Report
Form 4
Azad David
Director
Transactions
- Award
Director Stock Options
2012-01-03+15,000→ 15,000 totalExercise: $3.48Exp: 2022-01-02→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]Exercise price is closing price of Issuer's common stock on January 3, 2012.
- [F2]Twenty-five percent (25%) of shares underlying options vest on, and are exercisable commencing, each of March 31, 2012, June 30, 2012, September 30, 2012 and December 31, 2012.
- [F3]Not Applicable.